Bayer’s Drop of the Future

October, 2020    SMM-219 Bayer’s Drop of the Future With the rising importance of the ‘patient payer,’ the Bayer/One Drop business model brings together capabilities that neither firm possesses in full. Not only did this confirm...

The Science of the Deal

October, 2020    SMM-218 The Science of the Deal This article describes the early findings from my work with Zaki Sallem, one of the Doctoral Candidates I supervise. It gives new insight into what drives and shapes the construction of IP deals in...

Stop That!

September, 2020    SMM-217 Stop That! Everywhere in our industry, I see thinking that works well for scientists. Questions like ‘how will factor x impact on situation y?’ This way of thinking has its place, especially where confounding factors can...